China approves one more COVID-19 vaccine for emergency use

news
China approves one more COVID-19 vaccine for emergency use
Yuan Quan,unreguser
© Provided by N.C.N. Limited
A medical worker prepares a vaccine at a temporary COVID-19 vaccination site at a company in the ZPark Phase 2 in Haidian District of Beijing, capital of China, Feb. 22, 2021. (Xinhua/Ren Chao)
BEIJING, March 17 (Xinhua) -- China has approved the emergency use of a self-developed recombinant protein subunit vaccine against COVID-19, its main developer, the Institute of Microbiology under the Chinese Academy of Sciences, said on Wednesday.
The vaccine (CHO Cells) completed phase-1 and phase-2 clinical trials in October 2020. Results support the safety and immunogenicity of this vaccine, with no severe adverse reactions reported.

Related Keywords

Ecuador ,Beijing ,China ,Indonesia ,Pakistan ,Uzbekistan ,Chinese ,Xinhua Ren Chao ,Institute Of Microbiology ,Anhui Zhifei Longcom Biopharmaceutical Co ,Chinese Academy Of Sciences ,Haidian District ,Ren Chao ,Chinese Academy ,Anhui Zhifei Longcom Biopharmaceutical ,ஈக்வடார் ,பெய்ஜிங் ,சீனா ,இந்தோனேசியா ,பாக்கிஸ்தான் ,உஸ்பெகிஸ்தான் ,சீன ,நிறுவனம் ஆஃப் நுண்ணுயிரியல் ,சீன கலைக்கழகம் ஆஃப் அறிவியல் ,ரென் குழப்பம் ,சீன கலைக்கழகம் ,